Please assess the completion status of the following clinical trial:

Trial Title: Injection Versus Splinting in Carpal Tunnel Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female aged ≥ 18 years~* A clinical diagnosis of unilateral or bilateral CTS as made by a GP or trained clinician according to the diagnostic criteria~* Mild (e.g. intermittent paraesthesia) or moderate (e.g. constant paraesthesia, reversible numbness and / or pain) severity CTS of idiopathic nature~* Symptom duration of episode of at least 6 weeks~* Written informed consent provided by the patient, prior to any trial specific procedures~Exclusion Criteria:~* Steroid injection or night splints for CTS in the affected wrist within preceding 6 months~* Any previous surgery on the affected wrist~* Severe CTS exhibiting constant numbness or pain, constant sensory loss, severe thenar muscle atrophy or symptom severity which requires the patient to be referred for a surgical opinion~* Clinical suspicion of local or systemic sepsis or infection~* Current or previous infection of the affected wrist~* Trauma to the affected hand requiring surgery or immobilisation in the previous 12 months~* Unable to tolerate the study interventions~* Unable to understand and complete self-report questionnaires written in English~* Inter-current illness including, but not limited to:~  * poorly controlled thyroid disease~ * poorly controlled diabetes mellitus~ * vibration-induced neuropathy~ * inflammatory joint disease~ * suspected complex neurological conditions~ * any other severe medical illness which in the opinion of the local Principal Investigator (or other authorised clinical delegate) precludes trial participation~* Pregnant or lactating females~* Receiving anticoagulants~* Any history of hypersensitivity to Depo-Medrone or any of its excipients~* Allergy to any of the splint materials~* Known abuse of drugs or alcohol~* Involved in on-going litigation cases for their condition

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Steroid Injection (Type: ACTIVE_COMPARATOR): Single steroid injection into Carpal Tunnel (as Depo-medrone 20mg)
- Wrist Splint (Type: ACTIVE_COMPARATOR): Wrist splint to be worn at night

Based on this trial design, predict the completion outcome and termination type (if applicable).